A Randomized, Open-Label, Active-Control, Phase-IV clinical study evaluating efficacy and safety of Resveratrol as an adjuvant therapy in patients with Diabetes, Dyslipidemia and Hypertension

Rakesh Ojha0 个研究点目标入组 180 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Diabetes study:
•Patients of either gender with known T2DM, aged between 20 and 65 years
•Patient with borderline blood lipid abnormality and not taking any hypolipidemic agents
•Patient is on stable monotherapy of Glimeperide 2 mg
•Patient willing to use Plant based therapy (RESVERATROL) with gold standard therapy in management of their T2DM.
•Dylipidemia study:
•Patients with either sex in the age group of 20-65 years suffering from dyslipidemia
•Patient who are on stable therapy of Atorvastatin 10 mg tablet
•Patient willing to use Plant based therapy (RESVERATROL) with gold standard therapy (Statin) in management of dyslipidemia.
•Hypertension study:
•Patients of either sex, aged 20-65 yrs
•Patients with Stage I hypertension (SBP 140â??159 mmHg and DBP 90â??99 mmHg)
•Patients taking monotherapy of Telmisartan 20 mg
•Patient willing to use Plant based therapy (RESVERATROL) with gold standard therapy (Telmisartan 20 mg) in management of hypertension.

•Diabetes study:
•Patients who are willing to use other antioxidant supplementation rather than RESVERATROL
•Patients with type 1 diabetes, pregnant women and lactating mothers
•Patients with dyslipidemia and taking lipid lowering therapy including statin
•Patients with history of severe heart disease, hepatic and renal dysfunction
•Patients taking/requiring beta â?? blocker and any drug which produce hyperglycemia or hypoglycemia.
•Patients with history of allergy with grapes and consume alcohol daily
•Dylipidemia study:
•Patients who are willing to use other antioxidant supplementation rather than RESVERATROL
•Pregnant women and lactating mothers
•Patients taking/requiring any drug which affect blood lipid level
•Patients with history of diabetes, severe heart disease, hepatic and renal dysfunction
•Patients with history of allergy with grapes and consume alcohol daily
•Hypertension study:
•Patients who are willing to use other plant based therapy rather than RESVERATROL
•Patients taking/requiring any drug which affect blood pressure
•Pregnant women and lactating mothers
•Patients with history of severe heart disease, hepatic and renal dysfunction
•Patients with history of allergy with grapes and consume alcohol daily

发起方

Rakesh Ojha